 both vessels provides more durable relief, and the second (or additional)
intervention adds cost and potential risk.
There is likely a role for revascularization in patients
with symptoms consistent with CMI and occlusive disease isolated to single mesenteric vessel, particularly
the SMA. Patients with CMI typically have MAOD
affecting both the CA and the SMA or all three of the
mesenteric vessels as noted, and there has been a classic
teaching that stressed the